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Supplementary Note 1 
Case reports from individuals described in Table 1 
Individual 1; de novo, c.143C>A, p.T48N 
This is a 6.9-year-old female born to non-consanguineous, healthy parents. She had congenital microcephaly 
(head circumference of 31 cm at 1 month old) and intra-uterine growth retardation (birth weight 2260 g). She 
has moderate to severe global developmental delay. She walked independently from 24 months of age, and 
speaks in short sentences with difficult articulation at 6.9 years of age. She has abnormal mineralisation of the 
skull, bilateral ethmoidal, zygomatic, malar and mandibular hypoplasia, defects of the orbital floor, and 
hemivertebrae (L3). She does not have cardiac anomalies. She has eyelid hypoplasia, corneal ulceration and 
strabismus. At 6.8 years of age her height was 119 cm (0.5 SD), weight was 25.8 Kg (2 SD) and head 
circumference was 46 cm (-3 SD). She has sloping forehead, broad eyebrows, small lower eyelids, hypoplastic 
supraorbital ridges, bulbous nasal tip, microretrognathia, high arched palate, abnormal pinnae, low set ears and 
short neck. Hands and feet are also short with hypoplastic thumbs with limited metacarpophalangeal flexion, 
clinodactyly of 5th fingers and brachydactyly of toes. The initial clinical suspicion was a syndromic 
mandibulofacial dysostosis with microcephaly. 
 
Individual 2; de novo, c.316G>A, p.G106R 
This is an 8.4-year-old female born to consanguineous, healthy parents, without other affected individuals in her 
family. She had intra-uterine growth retardation, congenital microcephaly and neonatal feeding difficulties. She 
had a normal computed tomography scan at birth. She was also noted to have cardiac anomalies prenatally. She 
had a dysplastic tricuspid valve, tricuspid regurgitations and secundum atrial septal defect that were treated 
surgically at 11 months of age. She has moderate global developmental delay. She could sit unsupported at 18 
months, walked independently from 23 months of age, and said her first words from 2.5 years of age. She is fed 
via a gastrostomy tube. She has constipation and gastroesophageal reflux. At 6.7 years of age her height was 
105.3 cm (-2.82 SD), weight was 16.4 Kg (-2.28 SD) and head circumference was 43.5 cm (-7.47 SD). She has 
broad eyebrows, hypoplastic supraorbital ridges, epi- and telecanthus, bulbous nasal tip, thin upper lip, 
micrognathia and low set ears. The initial clinical suspicion was a Kabuki-like syndrome. 
 
Individual 3; de novo, c.324dupA, p.R109TfsTer8 
This is an 8.4-year-old female born to non-consanguineous, healthy parents. She had congenital microcephaly, a 
cleft palate, and neonatal feeding difficulties. The cleft palate was corrected surgically. She was also noted to 
have cardiac anomalies neonatally. She had a functional bicuspid aortic valve with fusion of the left and right 
coronary cusps, and trace aortic regurgitation. However, by 3 years of age her heart scan showed a structurally 
and functionally normal heart with a trileaflet aortic valve. She had mild global developmental delay and autistic 
traits. She walked independently from 17 months of age and said her first word from 12 months of age. She has 
conductive deafness that required grommets, premature thelarche and joint hypermobility. No ophthalmological, 
urogenital, immunity or brain anomalies have been detected. At 26 months of age her height was 90.3 cm (0.86 
SD), weight was 11.3 Kg (-0.41 SD) and head circumference was 44.5 cm (-2.11 SD). She has broad eyebrows, 
hypoplastic supraorbital ridges, epi- and telecanthus, hypertelorism, bulbous nasal tip, thin upper lip and 
micrognathia. The initial clinical suspicion was a Kabuki-like syndrome. 
 
Individual 4; de novo, c.325C>G, p.R109G 
This is an 18.3-year-old male born to non-consanguineous, healthy parents. He had intra-uterine growth 
retardation, neonatal hypotonia, and neonatal feeding difficulties. He had mild global developmental delay. He 
could sit unsupported at 1 year of age, walked independently from 1.5 years of age, and said his first words from 
12 months of age. He has an IQ level of 50. He has small bilateral high intensity signals in the peritrigonal 
regions of the deep frontoparietal white matter. He is not known to have cardiac anomalies, but has not had any 
cardiac imaging. He has constipation, glaucoma, cryptorchidism and joint hypermobility. At 17.4 years of age 
his height was 172.5 cm (-0.45 SD), weight was 66.4 Kg (0.06 SD) and head circumference was 52.2 cm (-2.62 
SD). He has broad eyebrows, prominent supraorbital ridges, epicanthus, long eyelashes, malar hypoplasia, 
prominent ears, bulbous nasal tip, thin upper lip, micrognathia, pes planus, and sandal gap. The initial clinical 
suspicion was a Kabuki-like syndrome. 
 
Individual 5; de novo, c.325C>T, p.R109* 
This is an eight-month-old male born to non-consanguineous, healthy parents. The pregnancy was complicated 
by maternal hypertension and early pre-eclampsia and polyhydramnios. He was delivered at 35 weeks 4 days 
gestation and weighed 3.20Kg. He initially required positive pressure ventilation for poor respiratory. He 
required feeding via a naso gastric tube feeding and a gastrostomy tube was placed at four months of age due to 
continued poor growth and oral aversion. He has developmental delays with minimal babbling and poor head 
control at eight months of age. He could roll from belly to back but could not sit unassisted. He has an atrial 
septal defect, moderate right atrial enlargement and mild right ventricular dilation. He has been diagnosed with 
dysphagia and failure to thrive. At eight months of age, his length was 68 cm (-1.45 SD), weight was 6.18 Kg (-
3.14 SD) and head circumference was 43 cm (-0.45 SD). Dysmorphic features noted on physical exam included 
plagiocephaly, sparse/furry scalp hair, frontal bossing, epicanthal folds, sparse eyebrows, downslanting 
palpebral fissures, cupped and prominent ears, an ear lobe crease on the right ear, a thin upper lip, and paucity of 
subcutaneous fat. Physical exam also noted hypotonia with a significant head lag and the inability to sit 
independently. His initial clinical suspicion was Mowat-Wilson-like syndrome 
 
Individual 6; de novo, c.343 C>T; p.P115S 
This is a 4-years 8 month-old male born to non-consanguineous, healthy parents. He had no prenatal and 
neonatal anomalies. He has global developmental delay. He walked independently from 18 months of age, and 
said his first words at 2 years of age. He spoke in full sentences at almost 4 years. He has no major 
malformations. He has mild diffuse hypotonia, esophoria, anxiety-induced tic. At 4 years 8 months of age his 
height was 111.7 cm (+1 SD), weight was 17.6 Kg (-0.09 SD) and head circumference was 49 cm (-1.09 SD). 
On physical exam, he was found to be thin. He had long palpebral fissures (length at the 90
th
 percentile), broad 
eyebrows and protruding ears bilaterally. He also had micrognathia, a high-arched palate, a long nasal bridge 
with small ala nasi. Flat feet were noticed bilaterally, with talus pronation.  
 
Individual 7; de novo, c.364G>A, p.E122K 
This is a 16.4-year-old female born to non-consanguineous, healthy parents. She had foetal ascites, which 
spontaneously resolved prenatally, and positional talipes. She had moderate global developmental delay. She 
could sit unsupported at 9 months, walked independently from 3 years of age, and said her first words from 3 
years of age. She has also autism spectrum disorder and attention deficit hyperactivity disorder. She does not 
have brain anomalies. She is not known to have cardiac anomalies, but has not had any cardiac imaging. She has 
left convergent strabismus, nasal polyps, and delayed puberty. At 16 years of age her height was 147.6 cm (-
2.59 SD), weight was 61.95 Kg (-0.69 SD) and head circumference was 52.7 cm (-1.94 SD). She has epicanthus, 
deep-set eyes, prominent creasing and lacrimal punctae of the lower eyelids, small low-set ears, unilateral single 




 toenails, contractures of the 5
th
 toes and pes planus. The initial clinical suspicion 
was of an unidentified genetic syndrome. 
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Additional GG, Xho1 restriction site, yeast 5’-500 bases, human EIF5A ORF optimised for yeast codon usage, 
yeast 3’-375 bases, Spe1 restriction site. 
Supplementary Table 1. List of plasmids used in this study. 
Plasmid Precursor Description Source 
pAV1360 YCplac111 sc LEU2  Rizzardi, et al. 
1
 
pAV2565 pC3294 sc LEU2 yeIF5A-S149P  Saini, et al. 
2
 
pAV2566 pC4351 hc URA3 GAL1 promoter-LDB17-His6-HA-
3C-ZZ  
Gutierrez, et al. 
3
 
pAV2569 pC3287 sc LEU2 yeIF5A Saini, et al. 
2
 
pAV2570 pC4353 hc URA3 GAL1 promoter-EAP1-His6-HA-
3C-ZZ  
Gutierrez, et al. 
3
 
pAV2571 pC3288 sc URA3 yeIF5A Saini, et al. 
2
 
pAV2578 pUC19 hEIF5A  This study 
pAV2580 pAV1360 and 
pAV2578 
sc LEU2 heIF5A This study 
pAV2584 pAV2580 sc LEU2 heIF5A-T48N  This study 
pAV2585 pAV2580 sc LEU2 heIF5A-G106R  This study 
pAV2586 pAV2580 sc LEU2 heIF5A-R109Tfs*8  This study 
pAV2587 pAV2580 sc LEU2 heIF5A-E122K  This study 
pAV2590 pAV2582 hc LEU2 heIF5A-R109Tfs*8  This study 
pAV2592 pAV1361 and 
pAV2578 
sc URA3 heIF5A This study 
 
Abbreviations used: h:human (human protein sequence with yeast optimised codon usage), hc: high copy 
number (2 micron) plasmid, sc: single copy number (centromeric) plasmid, y: yeast.  
 





Direction Primer (5’-3’) 
c.143C>A; p.T48N Forward CCACTTCTAAGAATGGTAAGCACGGTCACGCTAAAGTCC 
Reverse CCGTGCTTACCATTCTTAGAAGTGGACATTTCGACAATC
TTAC 













 As detected in individuals 
b
 For optimising the translation according to yeast codon usage but keeping the predicted truncated amino acid 
sequence of EIF5A seen in individual 3, the dupA was replaced by insC 
Abbreviation: CDS=Coding sequence 




J696  pAV2571(pC3288)[yeIF5AURA3] 
GP7439 J696 pAV2571[yeIF5A URA3] pAV2569 [yeIF5A LEU2] 
GP7440 GP7439 pAV2569[yeIF5A LEU2] 
GP7441 J696 pAV2571[yeIF5A URA3] pAV2580[heIF5ALEU2] 
GP7443 J696 pAV2571[yeIF5A URA3] pAV2565[yeIF5A-S149P LEU2] 
GP7444 GP7441 pAV2580[heIF5A LEU2] 
GP7446 GP7443 pAV2565[yeIF5A-S149P LEU2] 
GP7447 J696 pAV2571[yeIF5A URA3] pAV2584[heIF5A-T48N LEU2] 
GP7448 J696 pAV2571[yeIF5A URA3] pAV2585[heIF5A-G106R, LEU2] 
GP7449 J696 pAV2571[yeIF5A URA3] pAV2586[heIF5A-R109Tfs*8 LEU2] 
GP7450 J696 pAV2571[yeIF5A URA3] pAV2587[heIF5A-E122K LEU2] 
GP7455 GP7447 pAV2584[heIF5A-T48N LEU2] 
GP7456 GP7450 pAV2587[heIF5A-E122K LEU2] 
GP7469 GP7444 pAV2580[heIF5A LEU2] pAV2592[heIF5A URA3] 
GP7474 GP7448 pAV2585[heIF5A-G106R, LEU2] 
GP7480 GP7469 pAV2592[heIF5A URA3] 
GP7482 GP7480 pAV2592[heIF5A URA3] pAV2586[heIF5A-R109Tfs*8 LEU2] 
GP7484 GP7480 pAV2592[heIF5A URA3] YCplac111[LEU2] 
GP7485 GP7480 pAV2592[heIF5A URA3] pAV2590[heIF5A-R109Tfs*8 LEU2] 
GP7490 GP7444 pAV2580[heIF5A LEU2] pAV2566[GAL1 promoter-LDB17-His6-HA-3C-ZZ 
URA3] 
GP7491 GP7455 pAV2584[heIF5A-T48N LEU2] pAV2566[GAL1 promoter-LDB17-His6-HA-
3C-ZZ URA3] 
GP7492 GP7474 pAV2585[heIF5A-G106R, LEU2] pAV2566[GAL1 promoter-LDB17-His6-
HA-3C-ZZ URA3] 
GP7493 GP7456 pAV2587[heIF5A-E122K LEU2] pAV2566[GAL1 promoter-LDB17-His6-
HA-3C-ZZ URA3] 
GP7500 GP7444 pAV2580[heIF5A LEU2] pAV2570[GAL1 promoter-EAP1-His6-HA-3C-ZZ 
URA3] 
GP7501 GP7455 pAV2584[heIF5A-T48N LEU2] pAV2570[GAL1 promoter-EAP1-His6-HA-
3C-ZZ URA3] 
GP7502 GP7474 pAV2585[heIF5A-G106R, LEU2] pAV2570[GAL1 promoter-EAP1-His6-
HA-3C-ZZ URA3] 
GP7503 GP7456 pAV2587[heIF5A-E122K LEU2] pAV2570[GAL1 promoter-EAP1-His6-HA-
3C-ZZ URA3] 
a
 The genotype for all yeast strains is MATα trp1-63 ura3-52 leu2-3 leu2-112 GAL2+ gcn2Δ tif51b::NAT 
tif51a::KANMX4 from Saini, et al. 
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Supplementary Figure 1. Individual 3 cDNA Sequencing.  
Lymphoblastoid cells from Individual 3 were harvested either after 6-hrs-treatment with 
puromycin (200µg/mL) or not, washed in PBS and then kept at -80°C. After standard reverse 
transcription, cDNA from both conditions were Sanger sequenced bidirectionally. While 
cDNA sequences from puromycin untreated cells only show the WT allele, the cDNA 
sequences from puromycin treated cells show low peaks for other nucleotides compatible 
with the frameshift allele
 
Supplementary Figure 2. Summary of the yeast strain construction.  
A yeast codon and expression optimised hEIF5A cDNA was synthesised and cloned into 
yeast plasmid vectors, which were subsequently subject to site-directed mutagenesis. The 
J696 strain, with both TIF51A and TIF51B genes deleted, was transformed with the indicated 
vectors to create strains for this study. 
 
 
Supplementary Figure 3. Growth of human eIF5A alleles in yeast. 
Growth of strains with indicated eIF5A alleles on synthetic dextrose (SD) plus Tryptophan (+W) (left) and SD+W+ Uracil (URA) + 5-
Fluoroorotic acid (5-FOA) incubated for 2, 3, 5 and 10 days at 25°C, 30°C and 37°C (right). Small colonies with heIF5A p.T48N only (yellow 
circles) and p.G106R only (blue circle) were detected after 10 days. Eighteen replicates per temperature per condition were performed. 
 
 
Supplementary Figure 4. Expression and hypusination of eIF5A-R109Tfs*8 in strains 
maintained with WT heIF5A. 
Immunoblots showing eIF5A expression (left) and hypusination (Hyp; right) comparing 
heIF5A-R109Tfs*8 from single copy or high-copy (hc) plasmids co-expressed with heIF5A-
WT. WT only controls are also shown. Cells were grown at 30°C in SCD-URA-LEU liquid 
medium. Data presentation and statistical treatment as described for Fig. 2b. Where 2 alleles 
are expressed their levels were quantified separately as indicated by the labelled half-width 




Supplementary Figure 5. Possible results for polysome profiling of eIF5A variants 
Under normal conditions (left panel), cells exhibit a Polysome-to-Monosome (P/M) ratio 
slightly above 1, and a low 60S/80S ratio. When there is a defect in translation initiation 
(middle panel), both the P/M and 60S/80S will be very low, whereas in translation elongation 
defects (right panel), the P/M ratio will be high and the 60S/80S ratio will be low. While the 
former situation would reflect a loss of interaction of eIF5A with the ribosome, the latter 




Supplementary Figure 6. Expression and hypusination of eIF5A alleles in Ldb17-HA 
PPT reporter strains. 
eIF5A expression (left) and hypusination (Hyp; right) amongst yeast strains haploid for 
heIF5A with the Haemagglutinin (HA)-tagged Ldb17 reporter, grown at 30°C in SCGal 
medium. Data presentation and statistical treatment as described for Fig. 2b. Full uncropped 
images of gel blots are shown in Supplementary Figure 14. 
 
 
Supplementary Figure 7. Expression and hypusination of eIF5A alleles in Eap1-HA 
PPT reporter strains. 
eIF5A expression (left) and hypusination (Hyp; right) amongst yeast strains haploid for 
heIF5A with the Haemagglutinin (HA)-tagged Eap1 reporter, grown at 30°C in SCGal 
medium. Data presentation and statistical treatment as described for Fig. 2b. Full uncropped 




Supplementary Figure 8. Extended Figure 3a. Growth of Yeast strains with Spermidine 
Growth of yeast strains haploid for human eIF5A (heIF5A) or its variants in minimum media 
supplemented with 0 mM (Untreated), 1mM, 2mM and 5mM of spermidine at 30°C until day 
2. Eighteen replicates per condition were performed. 
 
 
Supplementary Figure 9. Full scans of western blots shown in Fig 2b and Supplementary Fig 4. 
Scans of molecular weight marker, eIF5A, Hypusine and loading control (Pab1). The black boxes and black dashed-line boxes depict the areas 
shown in Fig. 2b and in Supplementary Fig 4, respectively.
 
 
Supplementary Figure 10. Full scans of western blots shown in Fig 2c. 
Scans of proteins tested (rows) in polysome profiles according to the strain tested (columns). The black boxes depict the areas shown in Fig. 2c. 
 
Supplementary Figure 11. Full scans of western blots shown in Fig 2d. 
Scans of molecular weight marker, HA-tagged reporters (Ldb17 and Eap1) and loading 
controls (eIF2α and Pab1). The black boxes depict the areas shown in Fig. 2d.
 
 
Supplementary Figure 12. Full scans of western blots shown in Fig 3b. 
Scans of proteins tested (rows) in polysome profiles under 1mM spermidine treatment 
according to the strain tested (columns). The black boxes depict the areas shown in Fig. 3b.
 
 
Supplementary Figure 13. Full scans of western blots shown in Fig 3c. 
Scans of molecular weight marker, HA-tagged reporter (Ldb17), eIF5A, hypusine and 
loading control (eIF2α) from strains untreated (first four lanes) and treated with 1mM 
spermidine (last four lanes). The black boxes depict the areas shown in Fig. 2d 
 
Supplementary Figure 14. Full scans of western blots shown in Supplementary Fig 6. 
Scans of molecular weight marker, eIF5A, hypusine and loading control (eIF2α) from strains with HA-tagged Ldb17 reporter. The black boxes 
depict the areas shown in Supplementary Fig. 6
 
 
Supplementary Figure 15. Full scans of western blots shown in Supplementary Fig 7. 
Scans of molecular weight marker, eIF5A, hypusine and loading control (Pab1) from strains 
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